WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. WXIBF Peers
See (WXIBF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WXIBF | $3.18 | +0.00% | 12.9B | 28.91 | $0.11 | N/A |
| NONOF | $68.97 | +2.03% | 303.6B | 18.89 | $3.62 | +2.41% |
| CSLLY | $79.18 | +0.56% | 153.5B | 29.13 | $2.72 | +1.68% |
| CMXHF | $151.02 | -7.39% | 73.1B | 27.71 | $5.45 | +1.83% |
| UCBJF | $199.89 | +0.00% | 38B | 31.78 | $6.29 | +0.79% |
| UCBJY | $98.27 | +0.02% | 37.3B | 31.17 | $3.15 | +0.80% |
| ARGNF | $547.60 | +0.08% | 33.4B | 33.35 | $16.42 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $10.25 | -1.49% | 16.9B | -1024.00 | -$0.01 | N/A |
| WXXWY | $6.45 | -1.15% | 13.3B | 29.30 | $0.22 | N/A |
Stock Comparison
WXIBF vs NONOF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NONOF has a market cap of 303.6B. Regarding current trading prices, WXIBF is priced at $3.18, while NONOF trades at $68.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas NONOF's P/E ratio is 18.89. In terms of profitability, WXIBF's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, WXIBF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSLLY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CSLLY has a market cap of 153.5B. Regarding current trading prices, WXIBF is priced at $3.18, while CSLLY trades at $79.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CSLLY's P/E ratio is 29.13. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, WXIBF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CMXHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CMXHF has a market cap of 73.1B. Regarding current trading prices, WXIBF is priced at $3.18, while CMXHF trades at $151.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CMXHF's P/E ratio is 27.71. In terms of profitability, WXIBF's ROE is +0.06%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, WXIBF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs UCBJF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, UCBJF has a market cap of 38B. Regarding current trading prices, WXIBF is priced at $3.18, while UCBJF trades at $199.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas UCBJF's P/E ratio is 31.78. In terms of profitability, WXIBF's ROE is +0.06%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, WXIBF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs UCBJY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, UCBJY has a market cap of 37.3B. Regarding current trading prices, WXIBF is priced at $3.18, while UCBJY trades at $98.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas UCBJY's P/E ratio is 31.17. In terms of profitability, WXIBF's ROE is +0.06%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, WXIBF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ARGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ARGNF has a market cap of 33.4B. Regarding current trading prices, WXIBF is priced at $3.18, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ARGNF's P/E ratio is 33.35. In terms of profitability, WXIBF's ROE is +0.06%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, WXIBF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ODTC Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, WXIBF is priced at $3.18, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ODTC's P/E ratio is 1.07. In terms of profitability, WXIBF's ROE is +0.06%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, WXIBF and ODTC have similar daily volatility (0.00).
WXIBF vs IVBXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, IVBXF has a market cap of 16.9B. Regarding current trading prices, WXIBF is priced at $3.18, while IVBXF trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas IVBXF's P/E ratio is -1024.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, WXIBF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs WXXWY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, WXXWY has a market cap of 13.3B. Regarding current trading prices, WXIBF is priced at $3.18, while WXXWY trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas WXXWY's P/E ratio is 29.30. In terms of profitability, WXIBF's ROE is +0.06%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, WXIBF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SBMFF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SBMFF has a market cap of 13B. Regarding current trading prices, WXIBF is priced at $3.18, while SBMFF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SBMFF's P/E ratio is 72.56. In terms of profitability, WXIBF's ROE is +0.06%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, WXIBF is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs GNMSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, GNMSF has a market cap of 12.6B. Regarding current trading prices, WXIBF is priced at $3.18, while GNMSF trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas GNMSF's P/E ratio is 12.03. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, WXIBF and GNMSF have similar daily volatility (0.00).
WXIBF vs SBHMY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, WXIBF is priced at $3.18, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, WXIBF's ROE is +0.06%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, WXIBF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TRSBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, TRSBF has a market cap of 7.7B. Regarding current trading prices, WXIBF is priced at $3.18, while TRSBF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas TRSBF's P/E ratio is 27.08. In terms of profitability, WXIBF's ROE is +0.06%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, WXIBF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AKBLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, WXIBF is priced at $3.18, while AKBLF trades at $28.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas AKBLF's P/E ratio is 42.73. In terms of profitability, WXIBF's ROE is +0.06%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, WXIBF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TLPPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, TLPPF has a market cap of 5.4B. Regarding current trading prices, WXIBF is priced at $3.18, while TLPPF trades at $15.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas TLPPF's P/E ratio is 177.78. In terms of profitability, WXIBF's ROE is +0.06%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, WXIBF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ABCZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, WXIBF is priced at $3.18, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, WXIBF and ABCZF have similar daily volatility (0.00).
WXIBF vs INCPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, WXIBF is priced at $3.18, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas INCPF's P/E ratio is -108.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, WXIBF and INCPF have similar daily volatility (0.00).
WXIBF vs GNNSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, GNNSF has a market cap of 4.7B. Regarding current trading prices, WXIBF is priced at $3.18, while GNNSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas GNNSF's P/E ratio is -27.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, WXIBF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs LABFF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, WXIBF is priced at $3.18, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas LABFF's P/E ratio is 28.95. In terms of profitability, WXIBF's ROE is +0.06%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, WXIBF and LABFF have similar daily volatility (0.00).
WXIBF vs ZLDPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, WXIBF is priced at $3.18, while ZLDPF trades at $57.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ZLDPF's P/E ratio is -21.55. In terms of profitability, WXIBF's ROE is +0.06%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, WXIBF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CAMRF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CAMRF has a market cap of 3.7B. Regarding current trading prices, WXIBF is priced at $3.18, while CAMRF trades at $63.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CAMRF's P/E ratio is 64.95. In terms of profitability, WXIBF's ROE is +0.06%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, WXIBF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs REGMF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, WXIBF is priced at $3.18, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas REGMF's P/E ratio is -13.32. In terms of profitability, WXIBF's ROE is +0.06%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, WXIBF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SHJBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SHJBF has a market cap of 3.1B. Regarding current trading prices, WXIBF is priced at $3.18, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, WXIBF's ROE is +0.06%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, WXIBF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TKBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, WXIBF is priced at $3.18, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, WXIBF's ROE is +0.06%, compared to TKBIF's ROE of N/A. Regarding short-term risk, WXIBF and TKBIF have similar daily volatility (0.00).
WXIBF vs MPSYF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, WXIBF is priced at $3.18, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, WXIBF's ROE is +0.06%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, WXIBF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BVNKF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, WXIBF is priced at $3.18, while BVNKF trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BVNKF's P/E ratio is 10.37. In terms of profitability, WXIBF's ROE is +0.06%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, WXIBF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BVNRY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, WXIBF is priced at $3.18, while BVNRY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BVNRY's P/E ratio is 10.27. In terms of profitability, WXIBF's ROE is +0.06%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, WXIBF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ASPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, WXIBF is priced at $3.18, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, WXIBF's ROE is +0.06%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, WXIBF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BTTAY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, WXIBF is priced at $3.18, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, WXIBF's ROE is +0.06%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, WXIBF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ONTTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ONTTF has a market cap of 1.9B. Regarding current trading prices, WXIBF is priced at $3.18, while ONTTF trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ONTTF's P/E ratio is -9.19. In terms of profitability, WXIBF's ROE is +0.06%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, WXIBF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs GLPGF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, GLPGF has a market cap of 1.8B. Regarding current trading prices, WXIBF is priced at $3.18, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas GLPGF's P/E ratio is -8.79. In terms of profitability, WXIBF's ROE is +0.06%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, WXIBF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BRCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.18, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BRCTF's P/E ratio is 18.42. In terms of profitability, WXIBF's ROE is +0.06%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, WXIBF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs GENSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.18, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas GENSF's P/E ratio is -325.12. In terms of profitability, WXIBF's ROE is +0.06%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, WXIBF and GENSF have similar daily volatility (0.00).
WXIBF vs PPTDF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PPTDF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.18, while PPTDF trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PPTDF's P/E ratio is 16.68. In terms of profitability, WXIBF's ROE is +0.06%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, WXIBF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BIESF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BIESF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.18, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BIESF's P/E ratio is -44.44. In terms of profitability, WXIBF's ROE is +0.06%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, WXIBF and BIESF have similar daily volatility (0.00).
WXIBF vs PHMMF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, WXIBF is priced at $3.18, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PHMMF's P/E ratio is 70.13. In terms of profitability, WXIBF's ROE is +0.06%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, WXIBF is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSBTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, WXIBF is priced at $3.18, while CSBTF trades at $35.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CSBTF's P/E ratio is -291.75. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, WXIBF and CSBTF have similar daily volatility (0.00).
WXIBF vs BRAXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, WXIBF is priced at $3.18, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, WXIBF's ROE is +0.06%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, WXIBF is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MEOBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, WXIBF is priced at $3.18, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, WXIBF's ROE is +0.06%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, WXIBF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ASCLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ASCLF has a market cap of 1.2B. Regarding current trading prices, WXIBF is priced at $3.18, while ASCLF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ASCLF's P/E ratio is -31.37. In terms of profitability, WXIBF's ROE is +0.06%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, WXIBF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NURPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, WXIBF is priced at $3.18, while NURPF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas NURPF's P/E ratio is 12.41. In terms of profitability, WXIBF's ROE is +0.06%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, WXIBF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SNBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SNBIF has a market cap of 1.1B. Regarding current trading prices, WXIBF is priced at $3.18, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SNBIF's P/E ratio is -51.72. In terms of profitability, WXIBF's ROE is +0.06%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, WXIBF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs HBMHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, WXIBF is priced at $3.18, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, WXIBF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PHGUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PHGUF has a market cap of 782.4M. Regarding current trading prices, WXIBF is priced at $3.18, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, WXIBF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BPMUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BPMUF has a market cap of 752.7M. Regarding current trading prices, WXIBF is priced at $3.18, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BPMUF's P/E ratio is 8.63. In terms of profitability, WXIBF's ROE is +0.06%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, WXIBF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CSPHF has a market cap of 703M. Regarding current trading prices, WXIBF is priced at $3.18, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, WXIBF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SOLTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SOLTF has a market cap of 597.3M. Regarding current trading prices, WXIBF is priced at $3.18, while SOLTF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SOLTF's P/E ratio is -36.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, WXIBF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BXPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BXPHF has a market cap of 568.7M. Regarding current trading prices, WXIBF is priced at $3.18, while BXPHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BXPHF's P/E ratio is -29.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, WXIBF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs INRLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, INRLF has a market cap of 527.2M. Regarding current trading prices, WXIBF is priced at $3.18, while INRLF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas INRLF's P/E ratio is -4.84. In terms of profitability, WXIBF's ROE is +0.06%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, WXIBF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs IDRSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, IDRSF has a market cap of 505.8M. Regarding current trading prices, WXIBF is priced at $3.18, while IDRSF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas IDRSF's P/E ratio is -1.45. In terms of profitability, WXIBF's ROE is +0.06%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, WXIBF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CKDXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CKDXF has a market cap of 485.9M. Regarding current trading prices, WXIBF is priced at $3.18, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, WXIBF's ROE is +0.06%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, WXIBF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AAVXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, AAVXF has a market cap of 461.9M. Regarding current trading prices, WXIBF is priced at $3.18, while AAVXF trades at $7.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas AAVXF's P/E ratio is -2.11. In terms of profitability, WXIBF's ROE is +0.06%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, WXIBF is less volatile compared to AAVXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TBGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, WXIBF is priced at $3.18, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to TBGNF's ROE of N/A. Regarding short-term risk, WXIBF and TBGNF have similar daily volatility (0.00).
WXIBF vs VBIZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, VBIZF has a market cap of 411.9M. Regarding current trading prices, WXIBF is priced at $3.18, while VBIZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas VBIZF's P/E ratio is 19.80. In terms of profitability, WXIBF's ROE is +0.06%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, WXIBF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PTCHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PTCHF has a market cap of 396.8M. Regarding current trading prices, WXIBF is priced at $3.18, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PTCHF's P/E ratio is 7.87. In terms of profitability, WXIBF's ROE is +0.06%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, WXIBF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CLVLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CLVLF has a market cap of 361.9M. Regarding current trading prices, WXIBF is priced at $3.18, while CLVLF trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CLVLF's P/E ratio is 14.44. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, WXIBF and CLVLF have similar daily volatility (0.00).
WXIBF vs CLTEF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CLTEF has a market cap of 351M. Regarding current trading prices, WXIBF is priced at $3.18, while CLTEF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CLTEF's P/E ratio is -4.91. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, WXIBF is less volatile compared to CLTEF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NWBO Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NWBO has a market cap of 347.5M. Regarding current trading prices, WXIBF is priced at $3.18, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas NWBO's P/E ratio is -4.02. In terms of profitability, WXIBF's ROE is +0.06%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, WXIBF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CLVLY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CLVLY has a market cap of 341.6M. Regarding current trading prices, WXIBF is priced at $3.18, while CLVLY trades at $6.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CLVLY's P/E ratio is 13.61. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, WXIBF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CYDY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CYDY has a market cap of 326M. Regarding current trading prices, WXIBF is priced at $3.18, while CYDY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CYDY's P/E ratio is -13.22. In terms of profitability, WXIBF's ROE is +0.06%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, WXIBF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs IVEVF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, WXIBF is priced at $3.18, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, WXIBF's ROE is +0.06%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, WXIBF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PBBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, WXIBF is priced at $3.18, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, WXIBF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs HLOSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, HLOSF has a market cap of 282.6M. Regarding current trading prices, WXIBF is priced at $3.18, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas HLOSF's P/E ratio is -8.71. In terms of profitability, WXIBF's ROE is +0.06%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, WXIBF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PRRUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PRRUF has a market cap of 277.5M. Regarding current trading prices, WXIBF is priced at $3.18, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, WXIBF is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ORYZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ORYZF has a market cap of 249.8M. Regarding current trading prices, WXIBF is priced at $3.18, while ORYZF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ORYZF's P/E ratio is -53.72. In terms of profitability, WXIBF's ROE is +0.06%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, WXIBF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NWPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, WXIBF is priced at $3.18, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas NWPHF's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to NWPHF's ROE of N/A. Regarding short-term risk, WXIBF and NWPHF have similar daily volatility (0.00).
WXIBF vs MDCLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, WXIBF is priced at $3.18, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, WXIBF's ROE is +0.06%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, WXIBF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SLNCF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, WXIBF is priced at $3.18, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, WXIBF's ROE is +0.06%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, WXIBF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BOVNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, WXIBF is priced at $3.18, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, WXIBF's ROE is +0.06%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, WXIBF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs RAONF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, WXIBF is priced at $3.18, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas RAONF's P/E ratio is -20.33. In terms of profitability, WXIBF's ROE is +0.06%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, WXIBF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs FPHAF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, WXIBF is priced at $3.18, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to FPHAF's ROE of N/A. Regarding short-term risk, WXIBF and FPHAF have similar daily volatility (0.00).
WXIBF vs VSBC Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, WXIBF is priced at $3.18, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas VSBC's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, WXIBF and VSBC have similar daily volatility (0.00).
WXIBF vs FGHQF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, WXIBF is priced at $3.18, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, WXIBF's ROE is +0.06%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, WXIBF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs HNSBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, WXIBF is priced at $3.18, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, WXIBF's ROE is +0.06%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, WXIBF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BSEM Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BSEM has a market cap of 196.1M. Regarding current trading prices, WXIBF is priced at $3.18, while BSEM trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BSEM's P/E ratio is -21.05. In terms of profitability, WXIBF's ROE is +0.06%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, WXIBF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BRIBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, WXIBF is priced at $3.18, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, WXIBF's ROE is +0.06%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, WXIBF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SPHDF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SPHDF has a market cap of 189.9M. Regarding current trading prices, WXIBF is priced at $3.18, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SPHDF's P/E ratio is -3.28. In terms of profitability, WXIBF's ROE is +0.06%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, WXIBF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs IPHYF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, WXIBF is priced at $3.18, while IPHYF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas IPHYF's P/E ratio is -2.79. In terms of profitability, WXIBF's ROE is +0.06%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, WXIBF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NGENF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NGENF has a market cap of 176.5M. Regarding current trading prices, WXIBF is priced at $3.18, while NGENF trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas NGENF's P/E ratio is -8.66. In terms of profitability, WXIBF's ROE is +0.06%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, WXIBF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs GNFTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, WXIBF is priced at $3.18, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, WXIBF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ADOCY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, WXIBF is priced at $3.18, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, WXIBF's ROE is +0.06%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, WXIBF and ADOCY have similar daily volatility (0.00).
WXIBF vs OPORF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, WXIBF is priced at $3.18, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas OPORF's P/E ratio is 12.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, WXIBF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MLLCF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, WXIBF is priced at $3.18, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MLLCF's P/E ratio is -1.99. In terms of profitability, WXIBF's ROE is +0.06%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, WXIBF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AVCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, AVCTF has a market cap of 155.1M. Regarding current trading prices, WXIBF is priced at $3.18, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, WXIBF's ROE is +0.06%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, WXIBF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SCNLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, SCNLF has a market cap of 135.3M. Regarding current trading prices, WXIBF is priced at $3.18, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, WXIBF's ROE is +0.06%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, WXIBF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AAPGV Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, WXIBF is priced at $3.18, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas AAPGV's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to AAPGV's ROE of N/A. Regarding short-term risk, WXIBF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AMGXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, WXIBF is priced at $3.18, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, WXIBF's ROE is +0.06%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, WXIBF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PSTTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, WXIBF is priced at $3.18, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to PSTTF's ROE of N/A. Regarding short-term risk, WXIBF and PSTTF have similar daily volatility (0.00).
WXIBF vs EPRXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, WXIBF is priced at $3.18, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, WXIBF's ROE is +0.06%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, WXIBF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ADOIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, WXIBF is priced at $3.18, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, WXIBF's ROE is +0.06%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, WXIBF and ADOIF have similar daily volatility (0.00).
WXIBF vs JWCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, WXIBF is priced at $3.18, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, WXIBF and JWCTF have similar daily volatility (0.00).
WXIBF vs TRGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, WXIBF is priced at $3.18, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, WXIBF's ROE is +0.06%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, WXIBF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CMVLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, WXIBF is priced at $3.18, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, WXIBF's ROE is +0.06%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, WXIBF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MCURF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, WXIBF is priced at $3.18, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MCURF's P/E ratio is -16.90. In terms of profitability, WXIBF's ROE is +0.06%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, WXIBF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ACHFF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ACHFF has a market cap of 84.6M. Regarding current trading prices, WXIBF is priced at $3.18, while ACHFF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ACHFF's P/E ratio is -42.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, WXIBF is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PBIGF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, PBIGF has a market cap of 84.4M. Regarding current trading prices, WXIBF is priced at $3.18, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas PBIGF's P/E ratio is -7.22. In terms of profitability, WXIBF's ROE is +0.06%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, WXIBF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MSCLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, MSCLF has a market cap of 83M. Regarding current trading prices, WXIBF is priced at $3.18, while MSCLF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas MSCLF's P/E ratio is 2.61. In terms of profitability, WXIBF's ROE is +0.06%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, WXIBF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs KNTPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, KNTPF has a market cap of 77M. Regarding current trading prices, WXIBF is priced at $3.18, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, WXIBF's ROE is +0.06%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, WXIBF and KNTPF have similar daily volatility (0.00).
WXIBF vs ETXPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 12.9B. In comparison, ETXPF has a market cap of 76M. Regarding current trading prices, WXIBF is priced at $3.18, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 28.91, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, WXIBF and ETXPF have similar daily volatility (0.00).